HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.

Abstract
WT1 mutations have been described in a variety of syndromes, including Denys-Drash syndrome (DDS), which is characterized by predisposition to Wilms' tumor, genital abnormalities and development of early nephropathy. The most frequent WT1 defects in DDS are missense mutations located in exons 8-9. Our aim is to report a novel WT1 mutation in a 46,XY patient with a DDS variant, who presented a mild nephropathy with a late onset diagnosed during adolescence. He had ambiguous genitalia at birth. At 4 months of age he underwent nephrectomy (Wilms' tumor) followed by chemotherapy. Ambiguous genitalia were corrected and bilateral gonadectomy was performed. Sequencing of WT1 identified a novel heterozygous mutation (c.742A>T) in exon 4 that generates a premature stop codon (p.K248X). Interestingly, this patient has an unusual DDS nephropathy progression, which reinforces that patients carrying WT1 mutations should have the renal function carefully monitored due to the possibility of late-onset nephropathy.
AuthorsThatiana Evilen da Silva, Mirian Yumie Nishi, Elaine Maria Frade Costa, Regina Matsunaga Martin, Filomena Marino Carvalho, Berenice Bilharinho Mendonca, Sorahia Domenice
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 26 Issue 8 Pg. 1311-5 (Aug 2011) ISSN: 1432-198X [Electronic] Germany
PMID21559934 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon, Nonsense
  • WT1 Proteins
Topics
  • Base Sequence
  • Codon, Nonsense
  • Denys-Drash Syndrome (etiology, genetics, pathology)
  • Genes, Wilms Tumor
  • Heterozygote
  • Humans
  • Infant
  • Infant, Newborn
  • Kidney Diseases (complications, genetics)
  • Male
  • WT1 Proteins (genetics)
  • Wilms Tumor (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: